HOME › DRUGS › VENETOCLAX
ACTIVE SUBSTANCE / INN

VENETOCLAX

Brand name(s): VENCLEXTA, Venclyxto, VENETOCLAX
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NONE (TENTATIVE APPROVAL)
NDA208573
Leukemia, Lymphocytic, Chronic, B-Cell
ACTIVE SUBSTANCE
Venetoclax
REGULATORS
FDA · EMA
SPONSORS / MAH
DR REDDYS LABS LTD, AbbVie Deutschland GmbH & Co. KG, ABBVIE
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VENCLEXTANDA208573ABBVIEPrescription
VENETOCLAXANDA214733DR REDDYS LABS LTDNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VenclyxtoAbbVie Deutschland GmbH & Co. KGAuthorised04/12/2016Leukemia, Lymphocytic, Chronic, B-Cell

FULL INTELLIGENCE ON VENETOCLAX

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →